Clinical and laboratory features of B-cell chronic lymphocytic leukemia: a retrospective analysis of 503 cases
10.3760/cma.j.issn.1009-9921.2017.06.002
- VernacularTitle:慢性淋巴细胞白血病503例临床及实验室特征回顾性分析
- Author:
Heng LI
;
Wenjie XIONG
;
Huimin LIU
;
Shuhua YI
;
Rui LYU
;
Tingyu WANG
;
Zhen YU
;
Lugui QIU
;
Zengjun LI
- Keywords:
Leukemia,lymphocytic,chronic;
Cytogenetics;
Clinical features
- From:
Journal of Leukemia & Lymphoma
2017;26(6):325-330
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical and laboratory characteristics of patients with chronic lymphocytic leukemia (CLL). Methods 503 patients with CLL admitted from October 1998 to February 2015 were retrospectively analyzed. Baseline characteristics were compared using Chi-square test and Kaplan-Meier methodology was undertaken for survival analyses. Results The median age was 58 years (26-86 years):335 cases were male and 168 cases were female. 204 cases (40.5%) were at the clinical stage of Binet A, followed by Binet B (148 cases, 30.1%) and Binet C (151 cases, 29.3%). 108 cases (21.1%) had anemia at diagnosis, while 113 cases (26.5 %) had an elevated level of lactate dehydrogenase and the expression of CD38 was detected among 100 cases (29.1 %). Clonal abnormalities were observed using fluorescence in situ hybridization (FISH) analysis. Those involving 13q deletion were the most frequent (156 cases, 47.3 %), followed by IgH translocation (22.4 %), trisomy 12 (21.2 %) and 17p deletion (14.5 %). The mutational status of immunoglobulin heavy chain variable region was determined among 230 cases, 165 cases (71.7%) of which were found to be with mutated status. The most frequently encountered gene was V4-34 (28 cases, 12.4 %). The median progression-free survival (PFS) was 89.0 months (95 %CI 75.0-103.0 months), while the median overall survival was 129.0 months (95 %CI 106.9-151.1 months). Conclusion Compared with patients in the western world, CLL patients in this study are younger at diagnosis and have longer overall survival, which, to some extent, could reflects the characteristics of CLL patients in China.
